| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/25/2008 | CA2359987C 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 03/25/2008 | CA2277273C Integrin antagonists |
| 03/25/2008 | CA2268394C New heterocyclylmethyl-substituted pyrazol derivates |
| 03/25/2008 | CA2264822C Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 03/25/2008 | CA2243578C High affinity nucleic acid ligands of complement system proteins |
| 03/25/2008 | CA2174707C Chromone derivatives as nk1 and substance p antagonists |
| 03/25/2008 | CA2164642C Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof |
| 03/20/2008 | WO2008033754A2 Xanthine derivatives in methods and compositions for the treatment of vascular depression |
| 03/20/2008 | WO2008033465A1 Azetidinone derivatives and methods of use thereof |
| 03/20/2008 | WO2008033304A2 Compositions for promoting non-leaky collateral vascularization |
| 03/20/2008 | WO2008033299A2 Use of n-containing spirocompounds for the enhancement of cognitive function |
| 03/20/2008 | WO2008032814A1 Aspirin-containing pharmaceutical agent |
| 03/20/2008 | WO2008032764A1 Fused heterocyclic derivative |
| 03/20/2008 | WO2008032719A1 Adhesive preparation |
| 03/20/2008 | WO2008032718A1 Adhesive preparation |
| 03/20/2008 | WO2008032107A1 Solid dosage form of olmesartan medoxomil and amlodipine |
| 03/20/2008 | WO2008031811A1 Nitrate esters of aminoalcohols |
| 03/20/2008 | WO2008031513A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivates as stimulators of guanylate cyclase for cardiovascular disorders |
| 03/20/2008 | WO2008031501A2 2-phenoxy nicotine acid derivative and use thereof |
| 03/20/2008 | WO2008031332A1 Use of fucoidan in preparation of medicaments for the treatment of cardiovascular and cerebrovascular diseases |
| 03/20/2008 | WO2008031322A1 Application of acetylcholine esterase inhibitor medication of leonurus extractive as cholinomimetic |
| 03/20/2008 | WO2008003028A3 Pharmaceutical compositions comprising droxidopa |
| 03/20/2008 | WO2007149874A8 Imidazolidinone kv1.5 potassium channel inhibitors |
| 03/20/2008 | WO2007147163A3 Compositions comprising carotenoid analogs or derivatives and methods for synthesis |
| 03/20/2008 | WO2007144512A3 Diazeniumdiolate derivatives, method for the preparation thereof, pharmaceutical compositions thereof, and use of same in the fields of hypertension and cardiovascular pathologies |
| 03/20/2008 | WO2007138110A3 Compounds that interact with ion channels, in particular with ion channels from the kv family |
| 03/20/2008 | WO2007125385A3 Treatment of renal disorders, diabetic nephopathy and dyslipidemias |
| 03/20/2008 | WO2007124447A3 Use of chalcogenides for treating shock and other adverse conditions |
| 03/20/2008 | WO2001003644A3 Pyrazolopyrimidinone derivatives conjugated to thiophene moieties or benzo [fused] 5-membered heterocycles for erectile dysfunction |
| 03/20/2008 | US20080071069 For delivering DNA/RNA into cells |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070983 2-O- (Beta-D-Glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 03/20/2008 | US20080070974 4-((1E)-2-(((E)-2-fluoro-4-cyanostyrylsulfonyl)methylsulfonyl)vinyl)-3-fluoro-benzonitrile; mitogen activated protein kinase inhibitor; cell growth factor receptor antagonist; angiogenesis inhibitor, antiproliferative and anticarcinogenic agent; neurodegenerative diseases |
| 03/20/2008 | US20080070964 Opioid receptor active compounds |
| 03/20/2008 | US20080070961 storage stability; precipitation |
| 03/20/2008 | US20080070957 p-(2-alkoxy-2-acylethyl)biphenyl compounds; 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases,; lipid metabolism diseases; Peroxisome Proliferator-Activated Receptor modulator |
| 03/20/2008 | US20080070950 Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2- methylpropionic acid and its pharmaceutical compositions |
| 03/20/2008 | US20080070947 Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis |
| 03/20/2008 | US20080070936 Compounds specific to adenosine A1 receptors and uses thereof |
| 03/20/2008 | US20080070935 Isoquinoline, Quinazoline and Phthalazine Derivatives |
| 03/20/2008 | US20080070926 Therapeutic Combinations of Manidi Pine and a Statin |
| 03/20/2008 | US20080070922 DDPIV inhibitor: selected from (S)-1-{2-[5-cyanopyridin-2yl)amino]ethyl-aminoacetyl)-2-cyano-pyrrolidine, vildagliptin, Sitagliptin, saxagliptin; PDGF receptor tyrosine kinase inhibitor: selected from imatinib, imatinib methanesulfonate; impaired glucose metabolism; impaired glucose tolerance |
| 03/20/2008 | US20080070918 Heat Shock Protein-90 (HSP-90) inhibitors; cancer, inflammation, arthritis, angiogenesis, antimalaria, fungal and viral infections; 2-(4-Hydroxy-cyclohexylamino)-4-(3,7,7-trimethyl-5-oxo-5,6,7,8-tetrahydro-4H-cinnolin-1-yl)-benzamide for example; synthesis from corresponding benzonitriles |
| 03/20/2008 | US20080070917 Methods for administering levosimendan |
| 03/20/2008 | US20080070911 Ion channel modulating compounds and uses thereof |
| 03/20/2008 | US20080070906 Quinolinone derivatives |
| 03/20/2008 | US20080070903 New pyrimidine derivatives and new pyridine derivatives |
| 03/20/2008 | US20080070897 Having high bioavailability levels and reduced variability of bioavailability by use of dispersed, colloidal structures, colloids or analogous structures of the drug, a hydrophilic component (ethanol) , a surfactant such as polyglycerol, polyoxyethylene castor oil |
| 03/20/2008 | US20080070885 disorders related to beta-amyloid such as Alzheimer's disease, Down's Syndrome, memory and cognitive impairment, dementia, amyloidosis; (2R,4S) N-Butyl-4-hydroxy-2-methyl-4-((10S,13S)-10-methyl-8,11-dioxo-2-oxa-9,12-diaza-bicyclo[13.3.1]nonadeca-1(18),15(19),16-trien-13-yl)-butyramide for example |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | US20080070864 Modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors; N-[3-(2,4-dimethylphenyl)-4-oxo-3,4-dihydroquinazolin-2-ylmethyl]benzenesulfonamide |
| 03/20/2008 | US20080070843 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 03/20/2008 | US20080070841 Treating or preventing cardiovascular abnormal conditions related to thrombosis or embolism by administering serine proteinase inhibitor-1 (SERP-1) and a carrier; kits |
| 03/20/2008 | US20080070831 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications |
| 03/20/2008 | US20080070830 Homing of cells to myocardium |
| 03/20/2008 | US20080070828 Ace-Inhibitory Whey Hydrolysates |
| 03/20/2008 | US20080070259 Using presence or absence of mutation in metalloenzyme polynucleotides as diagnostic indicator of cardiovascular and neurodegenerative disorders |
| 03/20/2008 | US20080069886 Spironolactone nanoparticles, compositions and methods related thereto |
| 03/20/2008 | US20080069883 Applying to body tissue; adjust circulation; mixture containing penetration intensifiers, polymeric thickener, lipophic compound , water and buffer |
| 03/20/2008 | US20080069865 Congestive heart failure; antiischemic agents; administering calcitonin gene related peptide in thermoplastic biocompatible polymer; controlled release or maintenance therapy |
| 03/20/2008 | US20080069823 Attenuation of Reperfusion Injury |
| 03/20/2008 | US20080069801 Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications |
| 03/20/2008 | US20080069774 Targeting ligand specifically binding to an extracellular component of a cellular system, masking the extracellular component from interacting with a component of the cellular system; thrombotic occlusion and loss of vessel patency at the site of the vascular intervention |
| 03/20/2008 | CA2663503A1 Azetidinone derivatives and methods of use thereof |
| 03/20/2008 | CA2663297A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders |
| 03/20/2008 | CA2663129A1 Nitrate esters of aminoalcohols |
| 03/20/2008 | CA2662879A1 2-phenoxynicotinic acid derivatives and use thereof |
| 03/20/2008 | CA2662115A1 Methods for enhancing cognitive function |
| 03/19/2008 | EP1900815A2 In vivo production of small interfering RNAs that mediate gene silencing |
| 03/19/2008 | EP1900741A1 New process for the production of oxabispidines |
| 03/19/2008 | EP1900738A2 Substituted pyrroline kinase inhibitors |
| 03/19/2008 | EP1900728A1 Pharmaceutical composition comprising pyrazolone derivative |
| 03/19/2008 | EP1900380A1 Pharmaceutical composition for vascular occlusive disease |
| 03/19/2008 | EP1900374A1 Angiogenetic agent containing adrenomedulin as the active ingredient |
| 03/19/2008 | EP1900367A2 Hypoglycemic agent |
| 03/19/2008 | EP1900366A2 Hypoglycemic agent |
| 03/19/2008 | EP1900365A2 New endocannabinoid-like compounds and their use |
| 03/19/2008 | EP1900360A1 Homer a new target of treating psychiatric disorders |
| 03/19/2008 | EP1899339A1 1,2-dihydro-spiro(3h-indole-3-4 -piperidine) compounds as modulators of the mas receptor novel |
| 03/19/2008 | EP1899333A1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 03/19/2008 | EP1899330A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 03/19/2008 | EP1899320A1 SUBSTITUTED PYRR0LIDIN-2-0NES , PIPERIDIN-2-0NES AND ISOTHIAZOLIDINE-1, 1-DIOXIDES, THEIR USE AS KVl .5 POTASSIUM CHANNEL BLOCKERS AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM |
| 03/19/2008 | EP1899297A1 Zofenopril calcium in polymorph form c |
| 03/19/2008 | EP1898951A1 Pharmaceutical preparation containing an angiotensin ii receptor antagonist and a calcium channel blocker |
| 03/19/2008 | EP1898911A1 Nanoparticulate clopidogrel and aspirin combination formulations |
| 03/19/2008 | EP1682122B1 Combinations of valsartan, amiloride or triamterine, and a diuretic |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 03/19/2008 | EP1530573B1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 03/19/2008 | EP1499316B1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 03/19/2008 | EP1432715B1 Pyrimidine derivatives |
| 03/19/2008 | EP1399450B1 Benzoxazepine derivatives and their use as ampa receptor stimulators |
| 03/19/2008 | EP1362031B1 Pharmaceutically active piperidine derivatives |
| 03/19/2008 | EP1303496B9 Pyrimidine derivatives |
| 03/19/2008 | EP1200137B1 Agent for occluding blood vessels |
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | CN101146781A Spirocyclic thrombin receptor antagonists |
| 03/19/2008 | CN101146528A Pharmaceutical composition comprising hydroxylated nebivolol |
| 03/19/2008 | CN101146527A Methods for QT interval control |
| 03/19/2008 | CN101143866A Chlorophyll derivatives, preparation method and application thereof in medical agricultural chemicals |